安吉戴纳米克斯

US · ANGO #3631 按市值排名

11.24 -0.34 -2.94%

实时 - 追踪5344个代码 - 心跳于176秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

增持

最近一期（2026/Q3）披露持股的机构数量减少了2家。
机构持股总比例上升了0.3个百分点。

机构持股

机构持股比例: 93.43% +0.34pp
机构数量: 197 -2
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund57.36%

Hedge Fund32.09%

Individual/Insider10.36%

Public Company2.11%

Insurance Company1.13%

Government Pension Fund0.43%

Private Company0.17%

Family Office/Trust0.13%

主要股东截至 2026-06-30

BlackRock 9.20% · 3.80M 股

Point72 Asset Management, L.P. 7.41% · 3.06M 股

Systematic Financial Management LP 6.39% · 2.64M 股

Kevin Kotler 5.86% · 2.42M 股

Armistice Capital LLC 5.32% · 2.20M 股

Vanguard Capital Management, LLC 4.77% · 1.97M 股

Royce & Associates, LP 4.77% · 1.97M 股

Broadfin Capital, LLC 4.40% · 1.82M 股

Weber Capital Management, LLC 3.28% · 1.36M 股

Teachers Insurance and Annuity Association-College Retirement Equities Fund 2.65% · 1.10M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 32次买入 · 18次卖出

姓名	职务	持股比例
James Clemmer	Chief Executive Officer	1.52%
Howard Donnelly	Independent Non-Executive Chairperson	0.43%
Stephen Trowbridge	Chief Financial Officer	0.39%
Wesley Johnson	Independent Director	0.38%
Jan Reed	Independent Director	0.28%
Eileen Auen	Independent Director	0.28%
Karen Licitra	Independent Director	0.25%
Michael Tarnoff	Independent Director	0.23%
Laura Piccinini	Senior VP & GM of International	0.20%
Lorinda Burgess	Independent Director	0.16%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-07-29	Warren Nighan	Senior Vice President of Quality & Regulatory Affairs	Open Market Disposition	-23,370	$14.72
2026-07-21	Warren Nighan	Senior Vice President of Quality & Regulatory Affairs	Derivative Exercise and Sale	-1,671	$13.82
2026-07-21	Warren Nighan	Senior Vice President of Quality & Regulatory Affairs	Derivative Exercise and Retained	+4,023	--
2026-07-21	James Clemmer	Chief Executive Officer	Derivative Exercise and Sale	-26,728	$13.82
2026-07-21	James Clemmer	Chief Executive Officer	Derivative Exercise and Retained	+25,630	--
2026-07-21	Stephen Trowbridge	Chief Financial Officer	Derivative Exercise and Sale	-8,319	$13.82
2026-07-21	Stephen Trowbridge	Chief Financial Officer	Derivative Exercise and Retained	+7,977	--
2026-07-21	Laura Piccinini	Senior VP & GM of International	Derivative Exercise and Sale	-4,506	$13.82
2026-07-21	Laura Piccinini	Senior VP & GM of International	Derivative Exercise and Retained	+3,541	--
2026-07-21	Chad Campbell	Senior VP and GM of Vascular Access & Oncology Global Business Unit	Derivative Exercise and Sale	-2,330	$13.82
2026-07-21	Chad Campbell	Senior VP and GM of Vascular Access & Oncology Global Business Unit	Derivative Exercise and Retained	+4,136	--
2026-07-19	Warren Nighan	Senior Vice President of Quality & Regulatory Affairs	Sale to Issuer	-3,777	$13.51–14.14
2026-07-19	James Clemmer	Chief Executive Officer	Sale to Issuer	-45,711	$13.51–14.14
2026-07-19	Stephen Trowbridge	Chief Financial Officer	Sale to Issuer	-12,067	$13.51–14.14
2026-07-19	Laura Piccinini	Senior VP & GM of International	Sale to Issuer	-8,228	$13.51–14.14
2026-07-19	Chad Campbell	Senior VP and GM of Vascular Access & Oncology Global Business Unit	Sale to Issuer	-3,838	$13.51–14.14
2026-07-15	Lawrence Weiss	Chief Legal Officer	Sale to Issuer	-2,267	$14.14
2026-07-14	Jan Reed	Independent Director	Other Acquisition	+11,887	--
2026-07-14	Wesley Johnson	Independent Director	Other Acquisition	+11,887	--
2026-07-14	Howard Donnelly	Independent Non-Executive Chairperson	Other Acquisition	+11,887	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。